Search results
Moderna (MRNA) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 12 months agoModerna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. The company...
Is Moderna Building a Respiratory Vaccine Empire?
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) made a name for itself through its coronavirus vaccine. The vaccine has generated billions of dollars in earnings over the past...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 20 hours agoAlthough Moderna (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 6 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...
FDA authorizes Novavax's updated COVID vaccine
CBS News via Yahoo News· 8 months agoThe Food and Drug Administration announced Tuesday it had authorized Novavax's updated COVID-19 vaccine, adding a third option for Americans ages 12 and...
US approves updated COVID vaccines to rev up protection this fall
Associated Press via AOL· 9 months agoThe U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest...
Does This Message From Moderna Mean Bad News for Novavax?
Motley Fool· 9 months agoModerna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had...
CDC recommends updated Covid-19 vaccines for everyone 6 months and older
CNN via AOL· 9 months agoEveryone ages 6 months and older should get an updated Covid-19 vaccine, the US Centers for Disease...
Is Moderna Heading for a Critical Moment?
Motley Fool· 11 months agoModerna (NASDAQ: MRNA) has generated billions of dollars in sales and profit from its coronavirus vaccine. This doesn't mean the revenue opportunity is...
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
Motley Fool· 8 months agoPfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have been in agreement on a lot since the beginning of...
